selected scholarly activity
-
conferences
- Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV–Hepatitis C Virus Coinfection. Journal of Infectious Diseases. 80-86. 2016
- Impact of Drug Interactions on Choice of Antifungal Therapy in Treating IFI. A Case Report of Use of Posaconazole to Treat Fusarium Soft Tissue Infection in a Liver Transplant Patient on Sirolimus. International Journal of Infectious Diseases. S15-S15. 2008
-
journal articles
- Mortality, perioperative complications and surgical timelines in hip fracture patients: Comparison of the Spanish with the non-Spanish Cohort of the HIP ATTACK-1 trial.. Injury. 55:111827. 2024
- Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir. Clinical Infectious Diseases. 78:562-572. 2024
- Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies. The Lancet HIV. 11:e106-e116. 2024
- Eight-week glecaprevir/pibrentasvir in Canadian hepatitis C virus-infected, treatment-naïve, compensated cirrhotic people: CREST study. Future Virology. 19:361-370. 2024
- Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis. Clinical Drug Investigation. 43:681-690. 2023
- Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learning. BMC Medical Research Methodology. 22:223. 2022
- Functional recovery following hospitalisation of patients diagnosed with COVID-19: a protocol for a longitudinal cohort study. BMJ Open. 11:e053021-e053021. 2021
- Post-discharge after surgery Virtual Care with Remote Automated Monitoring-1 (PVC-RAM-1) technology versus standard care: randomised controlled trial. The BMJ. 374:n2209-n2209. 2021
- External validation of the 4C mortality score among COVID-19 patients admitted to hospital in Ontario, Canada: a retrospective study. Scientific Reports. 11:18638. 2021
- Inflammatory biomarkers as independent prognosticators of 28-day mortality for COVID-19 patients admitted to general medicine or ICU wards: a retrospective cohort study. Internal and emergency medicine. 16:1573-1582. 2021
- Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. The Lancet. 397:499-509. 2021
- Estimating an individual-level deprivation index for HIV/HCV coinfected persons in Canada. PLoS ONE. 16:e0249836-e0249836. 2021
- Post Discharge after Surgery Virtual Care with Remote Automated Monitoring Technology (PVC-RAM): protocol for a randomized controlled trial. CMAJ open. 9:E142-E148. 2021
- Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScopeⓇ—Global Registry for Emerging Fungal Infections. Journal of Infection. 81:802-815. 2020
- Listeria pericarditis in a lymphoma patient: Case report and literature review. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 5:182-186. 2020
- Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus. Clinical Infectious Diseases. 71:363-371. 2020
- Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis. Journal of Hepatology. 71:660-665. 2019
- Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV–Coinfected Patients in Clinical Care. Open Forum Infectious Diseases. 6:ofz055. 2019
-
Real‐world impact of direct acting antiviral therapy on health‐related quality of life in
HIV /Hepatitis C co‐infected individuals. Journal of Viral Hepatitis. 25:1507-1514. 2018 - Herpes Simplex Virus Colitis in a Patient with Newly Diagnosed Crohn’s Disease. Case Reports in Medicine. 2018:1-3. 2018
- Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study. BMC Infectious Diseases. 17:80. 2017
- Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease. Journal of Antimicrobial Chemotherapy. 72:3406-3413. 2017
- Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease. Journal of Antimicrobial Chemotherapy. 72:3501-3501. 2017
- Management of cytomegalovirus in hematopoietic stem cell transplant recipients: A review of novel pharmacologic and cellular therapies. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 2:32-40. 2017
- AMMI Canada position statement: The use of early antiretroviral therapy in HIV-infected persons. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 1:1-11. 2017
- Chronic obstructive pulmonary disease and HIV: are we appropriately screening?. AIDS Care. 28:1338-1343. 2016
- Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease. Journal of Antimicrobial Chemotherapy. 71:1747-1747. 2016
-
Fibroblast growth factor 23: associations with antiretroviral therapy in patients co‐infected with
HIV and hepatitis C. HIV Medicine. 17:373-379. 2016 - How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?. Clinical Infectious Diseases. 62:919-926. 2016
- Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease. Journal of Antimicrobial Chemotherapy. 71:718-726. 2016
- Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C–Coinfected Persons. Clinical Infectious Diseases. 62:242-249. 2016
- CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment. Canadian Journal of Infectious Diseases and Medical Microbiology. 2016:1-34. 2016
-
Opioid use and risk of liver fibrosis in
HIV /hepatitisC virus‐coinfected patients inC anada. HIV Medicine. 17:36-45. 2016 - Favourable IFNL3 Genotypes Are Associated with Spontaneous Clearance and Are Differentially Distributed in Aboriginals in Canadian HIV-Hepatitis C Co-Infected Individuals. International Journal of Molecular Sciences. 16:6496-6512. 2015
-
HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral‐treatedHIV /hepatitisC virus‐coinfected patients. HIV Medicine. 16:24-31. 2015 - Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia. Antimicrobial Agents and Chemotherapy. 58:5758-5765. 2014
- The Prospective Antifungal Therapy Alliance® Registry: A Two‐Centre Canadian Experience. Canadian Journal of Infectious Diseases and Medical Microbiology. 25:17-23. 2014
- Missed Opportunities for Hepatocellular Carcinoma Screening in an HIV/Hepatitis C Virus-Coinfected Cohort. Clinical Infectious Diseases. 57:1339-1342. 2013
- Treatment of invasive candidiasis in neutropenic patients: systematic review of randomized controlled treatment trials. Leukemia and Lymphoma. 54:1479-1487. 2013
-
HIV and hepatitisC virus coinfection inC anada: challenges and opportunities for reducing preventable morbidity and mortality. HIV Medicine. 14:10-20. 2013 - Successful Use of Posaconazole to Treat Invasive Cutaneous Fungal Infection in a Liver Transplant Patient on Sirolimus. Canadian Journal of Infectious Diseases and Medical Microbiology. 23:e44-e47. 2012
- The unfulfilled promise of efficacy trials in HIV/hepatitis C co-infected patients. Annals of Hepatology. 10:103-104. 2011
- Cohort Profile: The Canadian HIV-Hepatitis C Co-infection Cohort Study. International Journal of Epidemiology. 39:1162-1169. 2010